TrialThe Lancet. Haematology2025

Oral decitabine and cedazuridine maintenance after haematopoietic stem-cell transplantation in very high-risk acute myeloid leukaemia or myelodysplastic syndrome (GFM-DACORAL-DLI): a multicentre, single-arm, phase 2 trial.

Marie Robin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.